EP1180025A4 - IL-8 RECEPTOR ANTAGONISTS - Google Patents
IL-8 RECEPTOR ANTAGONISTSInfo
- Publication number
- EP1180025A4 EP1180025A4 EP00936368A EP00936368A EP1180025A4 EP 1180025 A4 EP1180025 A4 EP 1180025A4 EP 00936368 A EP00936368 A EP 00936368A EP 00936368 A EP00936368 A EP 00936368A EP 1180025 A4 EP1180025 A4 EP 1180025A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- receptor antagonists
- antagonists
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000010681 interleukin-8 receptors Human genes 0.000 title 1
- 108010038415 interleukin-8 receptors Proteins 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13666599P | 1999-05-28 | 1999-05-28 | |
US136665P | 1999-05-28 | ||
PCT/US2000/014660 WO2000072840A1 (en) | 1999-05-28 | 2000-05-26 | Il-8 receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1180025A1 EP1180025A1 (en) | 2002-02-20 |
EP1180025A4 true EP1180025A4 (en) | 2002-08-28 |
Family
ID=22473833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00936368A Withdrawn EP1180025A4 (en) | 1999-05-28 | 2000-05-26 | IL-8 RECEPTOR ANTAGONISTS |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1180025A4 (es) |
JP (1) | JP2003500443A (es) |
KR (1) | KR20020016806A (es) |
CN (1) | CN1352554A (es) |
AR (1) | AR029361A1 (es) |
AU (1) | AU766999B2 (es) |
BR (1) | BR0010863A (es) |
CA (1) | CA2374295A1 (es) |
CO (1) | CO5170528A1 (es) |
CZ (1) | CZ20014246A3 (es) |
HK (1) | HK1045256A1 (es) |
HU (1) | HUP0201302A3 (es) |
IL (1) | IL146053A0 (es) |
MX (1) | MXPA01012267A (es) |
NO (1) | NO20015774D0 (es) |
NZ (1) | NZ514728A (es) |
PL (1) | PL351947A1 (es) |
TR (1) | TR200103354T2 (es) |
WO (1) | WO2000072840A1 (es) |
ZA (1) | ZA200109627B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6230300A (en) * | 1999-07-21 | 2001-02-13 | Kadmus Pharmaceuticals, Inc. | Substituted guanidines and the use thereof |
EP1413302A3 (en) * | 1999-07-21 | 2004-05-12 | Kadmus Pharmaceuticals, Inc. | Substituted guanidines for the treatment of pain |
US6875759B1 (en) | 1999-07-21 | 2005-04-05 | Kadmus Pharmaceuticals | Substituted guanidines and the use thereof |
US6949567B2 (en) | 2001-02-26 | 2005-09-27 | 4Sc Ag | Compounds for the treatment of protozoal diseases |
DE10109204A1 (de) * | 2001-02-26 | 2002-09-19 | 4Sc Ag | Verbindungen zur Behandlung von Protozoen-Erkrankungen |
JP2006525254A (ja) | 2003-05-01 | 2006-11-09 | エフ.ホフマン−ラ ロシュ アーゲー | Ipアンタゴニストとしてのイミダゾリン−2−イルアミノ−フェニルアミド類 |
CN101531621B (zh) * | 2009-04-14 | 2012-08-15 | 厦门康奥克科技有限公司 | 一种胍类化合物的制备方法 |
AU2018354418A1 (en) * | 2017-10-27 | 2020-05-14 | Immunebridge Inc. | Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998006397A1 (en) * | 1996-08-15 | 1998-02-19 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
US5886044A (en) * | 1995-02-17 | 1999-03-23 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
WO2000072800A2 (en) * | 1999-05-28 | 2000-12-07 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
WO2001072960A2 (en) * | 2000-03-24 | 2001-10-04 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US605977A (en) * | 1898-06-21 | Bruno richard seifert | ||
US1953494A (en) * | 1926-08-26 | 1934-04-03 | Ig Farbenindustrie Ag | Process of preparing substituted guanidines |
US3914306A (en) * | 1972-09-22 | 1975-10-21 | Rorer Inc William H | Guanidines |
US5696290A (en) * | 1994-09-12 | 1997-12-09 | Monsanto Company | Synthesis of penta-substituted guanidines |
-
2000
- 2000-05-24 AR ARP000102556A patent/AR029361A1/es unknown
- 2000-05-24 CO CO00038191A patent/CO5170528A1/es not_active Application Discontinuation
- 2000-05-26 HK HK02105335.1A patent/HK1045256A1/zh unknown
- 2000-05-26 AU AU51690/00A patent/AU766999B2/en not_active Ceased
- 2000-05-26 CN CN00808133A patent/CN1352554A/zh active Pending
- 2000-05-26 IL IL14605300A patent/IL146053A0/xx unknown
- 2000-05-26 KR KR1020017015176A patent/KR20020016806A/ko not_active Withdrawn
- 2000-05-26 HU HU0201302A patent/HUP0201302A3/hu unknown
- 2000-05-26 CA CA002374295A patent/CA2374295A1/en not_active Abandoned
- 2000-05-26 TR TR2001/03354T patent/TR200103354T2/xx unknown
- 2000-05-26 EP EP00936368A patent/EP1180025A4/en not_active Withdrawn
- 2000-05-26 CZ CZ20014246A patent/CZ20014246A3/cs unknown
- 2000-05-26 MX MXPA01012267A patent/MXPA01012267A/es unknown
- 2000-05-26 JP JP2000620952A patent/JP2003500443A/ja not_active Withdrawn
- 2000-05-26 BR BR0010863-4A patent/BR0010863A/pt not_active IP Right Cessation
- 2000-05-26 WO PCT/US2000/014660 patent/WO2000072840A1/en not_active Application Discontinuation
- 2000-05-26 NZ NZ514728A patent/NZ514728A/en not_active Application Discontinuation
- 2000-05-26 PL PL00351947A patent/PL351947A1/xx not_active Application Discontinuation
-
2001
- 2001-11-22 ZA ZA200109267A patent/ZA200109627B/xx unknown
- 2001-11-27 NO NO20015774A patent/NO20015774D0/no not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5886044A (en) * | 1995-02-17 | 1999-03-23 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
WO1998006397A1 (en) * | 1996-08-15 | 1998-02-19 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
WO2000072800A2 (en) * | 1999-05-28 | 2000-12-07 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
WO2001072960A2 (en) * | 2000-03-24 | 2001-10-04 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
Non-Patent Citations (1)
Title |
---|
See also references of WO0072840A1 * |
Also Published As
Publication number | Publication date |
---|---|
HUP0201302A2 (hu) | 2002-12-28 |
IL146053A0 (en) | 2002-07-25 |
HUP0201302A3 (en) | 2003-02-28 |
EP1180025A1 (en) | 2002-02-20 |
NO20015774L (no) | 2001-11-27 |
AU766999B2 (en) | 2003-10-30 |
WO2000072840A1 (en) | 2000-12-07 |
AR029361A1 (es) | 2003-06-25 |
CA2374295A1 (en) | 2000-12-07 |
BR0010863A (pt) | 2002-02-19 |
NZ514728A (en) | 2004-04-30 |
CO5170528A1 (es) | 2002-06-27 |
HK1045256A1 (zh) | 2002-11-22 |
JP2003500443A (ja) | 2003-01-07 |
CZ20014246A3 (cs) | 2002-05-15 |
TR200103354T2 (tr) | 2002-06-21 |
AU5169000A (en) | 2000-12-18 |
CN1352554A (zh) | 2002-06-05 |
ZA200109627B (en) | 2002-11-28 |
MXPA01012267A (es) | 2002-07-30 |
PL351947A1 (en) | 2003-07-14 |
NO20015774D0 (no) | 2001-11-27 |
KR20020016806A (ko) | 2002-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1284956A4 (en) | ANTAGONISTS OF THE IL-8 RECEPTOR | |
PL352232A1 (en) | Il-8 receptor antagonists | |
DZ3309A1 (en) | Il-8 receptor antagonists | |
AU4560601A (en) | Il-8 receptor antagonists | |
IL145762A0 (en) | Il-8 receptor antagonists | |
PL351946A1 (en) | Il-8 receptor antagonists | |
EP1274415A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
AP2002002599A0 (en) | Il-8 receptor antagonists | |
EP1265905A4 (en) | IL-2 RECEPTOR ANTAGONISTS | |
IL146053A0 (en) | Il-8 receptor antagonists | |
EP1274413A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
EP1263427A4 (en) | ANTAGONISTS OF THE INTERLEUKIN 8 RECEPTOR | |
EP1274428A4 (en) | INTERLEUKIN-8 (IL-8) RECEPTOR ANTAGONISTS | |
EP1039903A4 (en) | INTERLEUKIN-8 RECEPTOR ANTAGONISTS | |
EP1047424A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
EP1194143A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
EP1261329A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
EP1185270A4 (en) | INTERLEUKIN-8 RECEPTOR ANTOGONISTS | |
HUP0202004A3 (en) | Il-8 receptor antagonists | |
PL352218A1 (en) | Il-8 receptor antagonists | |
IL140983A0 (en) | Il-8 receptor antagonists | |
EP1265603A4 (en) | IL-9 RECEPTOR ANTAGONISTS | |
EP1237548A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
ZA985975B (en) | IL-8 receptor antagonists | |
ZA985813B (en) | IL-8 receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011031 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI PAYMENT 20011031 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020716 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 31/155 A, 7A 61K 31/4168 B, 7A 61K 31/433 B, 7A 61P 9/10 B, 7A 61P 11/06 B, 7A 61P 13/12 B, 7C 07C 279/18 B, 7C 07D 233/04 B, 7C 07D 233/54 B, 7C 07D 271/10 B, 7C 07D 233/88 B, 7C 07D 233/50 B, 7C 07D 285/08 B |
|
17Q | First examination report despatched |
Effective date: 20030807 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20031218 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1045256 Country of ref document: HK |